
Jennifer Crombie, MD, discusses classification of diffuse large B-cell lymphoma (DLBCL) into distinct subtypes and treatment decisions based on molecular classifications.

Your AI-Trained Oncology Knowledge Connection!


Published: October 28th 2019 | Updated: